Valvular Heart Disease

Dopamine Agonists and the Risk of Cardiac Valve Regurgitation Schade, et al New Engl J Med. 2007; 356 (1) 29-38.

Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson’s Disease, Zanettini et al, N Engl J Med; 2007 Jan. 356(1): 39-46.